How much funding has Op-T-Mune, Inc raised?

Op-T-Mune, Inc has raised $300K in total funding, most recently a Grant round.

Who are Op-T-Mune, Inc's investors?

Op-T-Mune, Inc's investors include NIH NIAID, National Institutes of Health.

When was Op-T-Mune, Inc founded?

Op-T-Mune, Inc was founded in 2017.

Where is Op-T-Mune, Inc headquartered?

Op-T-Mune, Inc is headquartered in Denver, Colorado, United States.

What industry is Op-T-Mune, Inc in?

Op-T-Mune, Inc operates in Biotech, Healthcare.

How many employees does Op-T-Mune, Inc have?

Op-T-Mune, Inc has 1-10 employees.

Op-T-Mune, Inc

Denver, United States · Founded 2017 · $300K raised

Biotech

Healthcare

Headquarters: Denver, Colorado
Employees: 1–10
Founded: 2017
Business Model: B2G

Website: op-t-muneinc.com
Total Funding: $300K
Last Round: $300K GrantJan 2012
Rounds: 2

About

Op-T-Mune was founded to commercialize the intellectual property of Dr. David Wagner at the University of Colorado Denver. The company develops treatments and diagnostics for autoimmune diseases including type 1 diabetes and multiple sclerosis, focusing on controlling CD40-mediated autoimmune inflammation and identifying pathogenic cells as diagnostic tools.

Summary

Op-T-Mune, Inc is a Biotech company based in Denver, United States, founded in 2017. It has raised $300K in total across 2 rounds, most recently a $300K Grant round in Jan 2012. Investors include NIH NIAID and National Institutes of Health.